Keel Point’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.54M | Sell |
7,069
-637
| -8% | -$306K | 0.21% | 71 |
|
|
2026
Q1 | $3.79M | Sell |
7,706
-1,988
| -21% | -$1.08M | 0.25% | 56 |
|
|
2025
Q4 | $5.62M | Sell |
9,694
-604
| -6% | -$342K | 0.34% | 47 |
|
|
2025
Q3 | $4.99M | Buy |
10,298
+164
| +2% | +$76.3K | 0.31% | 54 |
|
|
2025
Q2 | $4.11M | Buy |
10,134
+1,645
| +19% | +$688K | 0.27% | 66 |
|
|
2025
Q1 | $4.22M | Sell |
8,489
-36
| -0.4% | -$19.5K | 0.33% | 59 |
|
|
2024
Q4 | $4.44M | Buy |
8,525
+272
| +3% | +$150K | 0.35% | 50 |
|
|
2024
Q3 | $5.11M | Buy |
8,253
+182
| +2% | +$108K | 0.43% | 36 |
|
|
2024
Q2 | $4.88M | Sell |
8,071
-557
| -6% | -$319K | 0.44% | 36 |
|
|
2024
Q1 | $5.01M | Buy |
8,628
+333
| +4% | +$187K | 0.52% | 35 |
|
|
2023
Q4 | $4.4M | Buy |
8,295
+1,243
| +18% | +$602K | 0.53% | 33 |
|
|
2023
Q3 | $3.57M | Sell |
7,052
-123
| -2% | -$65.5K | 0.49% | 38 |
|
|
2023
Q2 | $3.74M | Sell |
7,175
-342
| -5% | -$185K | 0.5% | 44 |
|
|
2023
Q1 | $4.33M | Sell |
7,517
-57
| -0.8% | -$32.1K | 0.63% | 28 |
|
|
2022
Q4 | $4.17M | Sell |
7,574
-124
| -2% | -$65.7K | 0.65% | 28 |
|
|
2022
Q3 | $3.9M | Buy |
7,698
+47
| +0.6% | +$26.3K | 0.67% | 30 |
|
|
2022
Q2 | $4.53M | Buy |
7,651
+275
| +4% | +$151K | 0.71% | 28 |
|
|
2022
Q1 | $4.36M | Buy |
7,376
+347
| +5% | +$199K | 0.65% | 34 |
|
|
2021
Q4 | $4.69M | Sell |
7,029
-101
| -1% | -$63.1K | 0.53% | 38 |
|
|
2021
Q3 | $4.07M | Buy |
7,130
+145
| +2% | +$79.6K | 0.53% | 37 |
|
|
2021
Q2 | $3.52M | Buy |
6,985
+735
| +12% | +$347K | 0.39% | 52 |
|
|
2021
Q1 | $2.85M | Buy |
6,250
+270
| +5% | +$129K | 0.28% | 63 |
|
|
2020
Q4 | $2.79M | Buy |
5,980
+559
| +10% | +$262K | 0.25% | 70 |
|
|
2020
Q3 | $2.39M | Buy |
5,421
+625
| +13% | +$258K | 0.22% | 63 |
|
|
2020
Q2 | $1.74M | Buy |
4,796
+87
| +2% | +$29.2K | 0.18% | 62 |
|
|
2020
Q1 | $1.33M | Sell |
4,709
-213
| -4% | -$67.2K | 0.17% | 58 |
|
|
2019
Q4 | $1.6M | Buy |
4,922
+800
| +19% | +$243K | 0.17% | 58 |
|
|
2019
Q3 | $1.2M | Buy |
4,122
+195
| +5% | +$55.8K | 0.15% | 70 |
|
|
2019
Q2 | $1.15M | Buy |
3,927
+345
| +10% | +$95K | 0.13% | 69 |
|
|
2019
Q1 | $980K | Buy |
3,582
+463
| +15% | +$115K | 0.11% | 70 |
|
|
2018
Q4 | $698K | Buy |
3,119
+1,764
| +130% | +$414K | 0.09% | 88 |
|
|
2018
Q3 | $331K | Buy |
1,355
+173
| +15% | +$39.8K | 0.04% | 138 |
|
|
2018
Q2 | $245K | Buy |
1,182
+70
| +6% | +$14.9K | 0.03% | 145 |
|
|
2018
Q1 | $230K | Buy |
+1,112
| New | +$233K | 0.03% | 142 |
|
Other funds holding TMO
Keel Point's TMO Position: Q2 2026 in Review
Keel Point reduced its Thermo Fisher Scientific (TMO) stake by 8.3% in Q2 2026, selling an estimated $306K and leaving 7,069 shares worth $3.54M. The position accounts for 0.21% of the portfolio, ranked #71.
Keel Point first reported a position in TMO in Q1 2018 and has held it in 34 quarters since. The position peaked at $5.62M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Keel Point held 7,069 shares of Thermo Fisher Scientific worth $3.54M as of Q2 2026.
- Keel Point sold 637 Thermo Fisher Scientific shares in Q2 2026, an estimated $306K.
- Thermo Fisher Scientific made up 0.21% of Keel Point's portfolio in Q2 2026, its #71 holding.
- Keel Point first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 34 quarters since.
- Keel Point's Thermo Fisher Scientific position peaked at $5.62M in Q4 2025.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Keel Point's 13F filing for Q2 2026, filed 14 Aug 2026.